SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a massive surge and volume spike following its strong Q4 earnings beat and optimistic Q1 guidance, which highlighted explosive demand for 800G and future 1.6T transceivers from hyperscale data centers. While some cheer its "AI plumbing play" potential and a potential short squeeze, others are debating the sustainability of its current valuation and the impact of a recent $250 million stock offering to fund its ambitious expansion plans.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is actively trending as its community rallies around the approaching 4/20 holiday, reinforcing its "culture coin" identity for the cannabis ecosystem on Solana. The discussion is split between strong belief in its long-term potential, driven by consistent community building and perceived outperformance of traditional cannabis stocks, and cautionary notes about speculative pump-and-dump activity.

Green Satoshi Token

Green Satoshi Token (GSTSOL) is sparking intense debate as many anticipate a significant upward move driven by increasing volume and technical signals, while a skeptical faction voices concerns over its history of dilution and prior performance amidst the broader altcoin market's renewed optimism.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMC Robotics (AMCI) is attracting significant attention as new strategic collaborations, global manufacturing expansion into Vietnam, and the imminent commercial launch of its NovaArm robot highlight its potential in the burgeoning AI and robotics sector. Despite community discussions around low trading volume and warrant exercises impacting the stock, investors are keenly anticipating major contracts to ignite a substantial run, especially with a tightly held float.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is in focus after securing new equity financing, with community sentiment divided between those optimistic about its expanding vehicle lineup and record sales growth, and skeptics highlighting persistent profitability concerns amid broader EV market challenges.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun (RUN) is highly active following its Q4 earnings, where strong quarterly beats were eclipsed by a cautious 2026 cash flow guidance and analyst downgrades. This triggered a significant sell-off, with the community sharply divided between those buying the dip and those expecting further decline amid broader solar sector volatility and claims of market manipulation.

Ultra Clean Holdings, Inc. engages in the development and supplying of critical subsystems, components and parts, and ultra-high purity cleaning and analytical services for the semiconductor industry. It operates through the Products and Services segments. The Products segment is involved in the design and manufacture of production tools, components, parts, and modules, and subsystems for the semiconductor and display capital equipment industry. The Services segment provides purity parts cleaning, process tool part recoating, surface encapsulation, and high sensitivity micro contamination analysis for the semiconductor device makers and wafer fabrication equipment. The company was founded in November 2002 and is headquartered in Hayward, CA.

Ultra Clean Hldgs Inc

Ultra Clean Holdings is trending due to mixed reactions surrounding a convertible debt offering that prompted short-term selling, despite the company reporting strong earnings and highlighting a positive long-term outlook for structural expansion in the semiconductor equipment and AI-driven advanced packaging markets.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing intense debate after earnings revealed ambitious capital expenditure plans to scale for immense AI infrastructure demand, prompting investor concern over near-term profitability, while a substantial backlog fuels bullish sentiment for long-term growth.

VanEck ETF Trust - VanEck Video Gaming and eSports ETF

VanEck Video Gaming and eSports ETF

VanEck Video Gaming and eSports ETF ($ESPO) is trending as it consistently appears in top-ranking lists for long-term communications sector holdings, fueled by sustained community interest in the enduring growth potential of the video gaming and esports industry.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is igniting investor excitement following its CEO's high-profile media appearances, which highlighted powerful patient testimonials and scientific advancements in IL-15 based cancer and longevity treatments, fueling community discussions about Anktiva's universal impact and intensifying pressure on shorts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 10.7% After Earnings Beat

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading 10.7% Higher on Better-Than-Expected Earnings...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen analysts that are presently covering the stock...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Posts Quarterly Earnings Results, Beats Expectations By $1.05 EPS

BioCryst Pharmaceuticals (NASDAQ:BCRX - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $1.12 earnings per share (EPS) for the quarter, beating...

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of +1,623.08% and +172.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BioCryst Pharmaceuticals Q4 Earnings Call Highlights

BioCryst Pharmaceuticals (NASDAQ:BCRX) outlined its full-year 2025 performance and priorities for 2026 during its fourth-quarter conference call, highlighting strong growth for its hereditary...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up After Better-Than-Expected Earnings

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up on Strong Earnings...

Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Public Sector Pension Investment Board Takes $2.01 Million Position in BioCryst Pharmaceuticals, Inc. $BCRX

Public Sector Pension Investment Board purchased a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) in the third quarter, according to its most recent filing with the...

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?

BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioCryst Pharmaceuticals (BCRX) to Release Earnings on Thursday

BioCryst Pharmaceuticals (NASDAQ:BCRX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

$BCRX Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.17 up 1000.00% YoY
• Reported revenue of $406.56M up 209.09% YoY
• BioCryst maintained full year 2026 global net ORLADEYO revenue guidance between $625M and $645M. BioCryst also maintained 2026 total revenue guidance between $635M and $660M.

Stocktwits

Biocryst Pharmaceuticals Inc.

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $1.17 up 1000.00% YoY
• Reported revenue of $406.56M up 209.09% YoY
• BioCryst maintained full year 2026 global net ORLADEYO revenue guidance between $625M and $645M. BioCryst also maintained 2026 total revenue guidance between $635M and $660M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Stocktwits Polls

The company announced robust Q4 2025 results with a $1.17 EPS, exceeding expectations, achieving profitability, and securing significant non-dilutive financing.

Active discussion surrounds over 40 million shares shorted and unusually high trading volume, leading many to speculate about an imminent short squeeze.

Traders are actively watching for a breakthrough past key resistance levels, with many forecasting a move towards $10 and higher targets up to $22 per share.

Optimism is building around the Navenibart program from the Astria acquisition and positive pediatric data for ORLADEYO, highlighting future growth potential.

Current Price	$8.75
Prev Close	$7.90
Open	$7.95
Dividend Yield	0.00%
50-Day Moving Average	$7.13
Beta	0.91
Avg. Volume	4.96M
PE Ratio	-167.02

52-Week High	$11.31
52-Week Low	$6.00
Market Capitalization	$1.96B
EPS (Annual)	-$0.43
Price to Book	-4.29
Revenue Per Employee	$777,089.66

BCRX
Biocryst Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BCRX News

BCRXBiocryst Pharmaceuticals Inc.